Validation of a Pediatric-Specific Abstinence Syndrome Assessment Tool
NCT ID: NCT00792415
Last Updated: 2025-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2009-11-30
2010-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
NCT02249026
Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence Syndrome
NCT03134703
Relational Parenting Group for Opioid-addicted Mothers
NCT00319241
Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence
NCT00555425
Contingency Management for Opioid and Stimulant Use Disorders in Primary Care
NCT05288751
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients receiving continuous opioid infusions for 5 days (at least 120 hours) or more
Exclusion Criteria
* Patients with deterioration of medical status requiring interventions of pain control, surgery, sedation, or re-intubation
2 Weeks
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Banner Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Teri Reyburn-Orne, RN, MSN, PNP
Role: PRINCIPAL_INVESTIGATOR
Banner Children's Hospital at Banner Desert Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardon Children's Medical Center
Mesa, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BHRI#05-08-0074
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.